tiprankstipranks
Trending News
More News >
NLS Pharmaceutics (NLSP)
NASDAQ:NLSP
US Market
Advertisement

NLS Pharmaceutics (NLSP) Technical Analysis

Compare
287 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
NLS Pharmaceutics’s (NLSP) Moving Averages Convergence Divergence (MACD) indicator is 0.07, suggesting NLS Pharmaceutics is a Sell.
NLS Pharmaceutics’s (NLSP) 20-Day exponential moving average is 2.22, while NLS Pharmaceutics’s (NLSP) share price is $2.58, making it a Buy.
NLS Pharmaceutics’s (NLSP) 50-Day exponential moving average is 2.17, while NLS Pharmaceutics’s (NLSP) share price is $2.58, making it a Buy.

NLS Pharmaceutics (NLSP) Pivot Points

Aug 20, 2025, 01:57 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.11
2.23
2.37
2.49
2.63
2.76
2.90
Fibonacci
2.23
2.33
2.39
2.49
2.59
2.66
2.76
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NLS Pharmaceutics (NLSP) Moving Averages

Aug 20, 2025, 01:57 AM
Period
Simple
Exponential
MA5
2.45Buy
2.45Buy
MA10
2.23Buy
2.31Buy
MA20
2.11Buy
2.22Buy
MA50
2.28Buy
2.17Buy
MA100
1.96Buy
2.18Buy
MA200
2.16Buy
2.66Sell
NLS Pharmaceutics’s (NLSP) 10-Day exponential moving average is 2.31, while NLS Pharmaceutics’s (NLSP) share price is $2.58, making it a Buy.
NLS Pharmaceutics’s (NLSP) 100-Day exponential moving average is 2.18, while NLS Pharmaceutics’s (NLSP) share price is $2.58, making it a Buy.
NLS Pharmaceutics’s (NLSP) stock price is $2.58 and NLS Pharmaceutics’s (NLSP) 50-day simple moving average is 2.28, creating a Buy signal.
NLS Pharmaceutics’s (NLSP) stock price is $2.58 and NLS Pharmaceutics’s (NLSP) 100-day simple moving average is 1.96, creating a Buy signal.
NLS Pharmaceutics’s (NLSP) stock price is $2.58 and NLS Pharmaceutics’s (NLSP) 200-day simple moving average is 2.16, creating a Buy signal.

NLS Pharmaceutics (NLSP) Technical Indicators

Aug 20, 2025, 01:57 AM
Name
Value
Implied Action
RSI (14)
64.93
Neutral
STOCH (9,6)
91.13
Sell
STOCHRSI (14)
91.13
Sell
MACD (12,26)
0.07
Sell
ADX (14)
18.08
Buy
Williams %R
-7.45
Sell
CCI (14)
175.22
Sell
ATR (14)
0.19
-
Ultimate Oscillator
65.89
Neutral
ROC
32.99
Buy
NLS Pharmaceutics’s (NLSP) Relative Strength Index (RSI) is 64.93, creating a Neutral signal.
NLS Pharmaceutics’s (NLSP) Trend Strength Indicator (ADX) is 18.08, creating a Buy signal.
NLS Pharmaceutics’s (NLSP) Commodity Channel Index (CCI) is 175.22, creating a Sell signal.
NLS Pharmaceutics’s (NLSP) Price Rate of Change (ROC) is 32.99, creating a Buy signal.

FAQ

Is NLSP a Buy, Hold, or Sell?
Based on NLSP’s technical indicators, NLSP is a Buy.
    What is NLSP’s RSI (14)?
    NLSP’s RSI (14) is 64.93, which suggests NLSP is a Neutral.
      What is NLSP’s MACD?
      NLSP’s MACD is 0.07, which suggests NLSP is a Sell.
        What is NLSP’s 5-day moving average?
        NLSP’s 5-day moving average is 2.45, which suggests NLSP is a Buy.
          What is NLSP’s 20-day moving average?
          NLSP 20-day moving average is 2.11, which suggests NLSP is a Buy.
            What is NLSP’s 50-day moving average?
            NLSP’s 50-day moving average is 2.28, which suggests NLSP is a Buy.
              What is NLSP’s 200-day moving average?
              NLSP’s 200-day moving average is 2.16, which suggests NLSP is a Buy.
                What is NLSP’s Williams % R (14)?
                NLSP’s Williams % R (14) is -7.45, which suggests NLSP is a Sell.
                  What is NLSP’s CCI (14)?
                  NLSP’s CCI (14) is 175.22, which suggests NLSP is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis